NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase - PubMed (original) (raw)
. 2003 Jan 17;278(3):1794-801.
doi: 10.1074/jbc.M205601200. Epub 2002 Nov 8.
Affiliations
- PMID: 12427752
- DOI: 10.1074/jbc.M205601200
Free article
NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase
Anne-Laure Perraud et al. J Biol Chem. 2003.
Free article
Abstract
We have recently characterized the protein product of the human NUDT9 gene as a highly specific ADP-ribose (ADPR) pyrophosphatase. We now report an analysis of the human NUDT9 gene and its potential alternative transcripts along with detailed studies of the enzymatic properties and cell biological behavior of human NUDT9 protein. Our analysis of the human NUDT9 gene and twenty-two distinct cloned NUDT9 transcripts indicates that the full-length NUDT9 alpha transcript is the dominant form, and suggests that an alternative NUDT9 beta transcript occurs as the result of a potentially aberrant splice from a cryptic donor site within the first exon to the splice acceptor site of exon 2. Computer analysis of the predicted protein of the NUDT9 alpha transcript identified an N-terminal signal peptide or subcellular targeting sequence. Using green fluorescence protein tagging, we demonstrate that the predicted human NUDT9 alpha protein is targeted highly specifically to mitochondria, whereas the predicted protein of the NUDT9 beta transcript, which is missing this sequence, exhibits no clear subcellular localization. Investigation of the physical and enzymatic properties of NUDT9 indicates that it is functional as a monomer, optimally active at near neutral pH, and that it requires divalent metal ions and an intact Nudix motif for enzymatic activity. Furthermore, partial proteolysis of NUDT9 suggests that NUDT9 enzymes consist of two distinct domains: a proteolytically resistant C-terminal domain retaining essentially full specific ADPR pyrophosphatase activity and a proteolytically labile N-terminal portion that functions to enhance the affinity of the C-terminal domain for ADPR.
Similar articles
- Sites of the NUDT9-H domain critical for ADP-ribose activation of the cation channel TRPM2.
Kühn FJ, Lückhoff A. Kühn FJ, et al. J Biol Chem. 2004 Nov 5;279(45):46431-7. doi: 10.1074/jbc.M407263200. Epub 2004 Sep 3. J Biol Chem. 2004. PMID: 15347676 - The crystal structure and mutational analysis of human NUDT9.
Shen BW, Perraud AL, Scharenberg A, Stoddard BL. Shen BW, et al. J Mol Biol. 2003 Sep 12;332(2):385-98. doi: 10.1016/s0022-2836(03)00954-9. J Mol Biol. 2003. PMID: 12948489 - Analysis of ligand binding and resulting conformational changes in pyrophosphatase NUDT9.
Gattkowski E, Rutherford TJ, Möckl F, Bauche A, Sander S, Fliegert R, Tidow H. Gattkowski E, et al. FEBS J. 2021 Dec;288(23):6769-6782. doi: 10.1111/febs.16097. Epub 2021 Jul 13. FEBS J. 2021. PMID: 34189846 Free PMC article. - Different Principles of ADP-Ribose-Mediated Activation and Opposite Roles of the NUDT9 Homology Domain in the TRPM2 Orthologs of Man and Sea Anemone.
Kühn F, Kühn C, Lückhoff A. Kühn F, et al. Front Physiol. 2017 Oct 31;8:879. doi: 10.3389/fphys.2017.00879. eCollection 2017. Front Physiol. 2017. PMID: 29163217 Free PMC article. Review. - TRPM2 Ca2+ permeable cation channels: from gene to biological function.
Perraud AL, Schmitz C, Scharenberg AM. Perraud AL, et al. Cell Calcium. 2003 May-Jun;33(5-6):519-31. doi: 10.1016/s0143-4160(03)00057-5. Cell Calcium. 2003. PMID: 12765697 Review.
Cited by
- A Systemic Review of the Integral Role of TRPM2 in Ischemic Stroke: From Upstream Risk Factors to Ultimate Neuronal Death.
Zong P, Lin Q, Feng J, Yue L. Zong P, et al. Cells. 2022 Jan 31;11(3):491. doi: 10.3390/cells11030491. Cells. 2022. PMID: 35159300 Free PMC article. - Mechanism of TRPM2 channel gating revealed by cryo-EM.
Xia S, Wang L, Fu TM, Wu H. Xia S, et al. FEBS J. 2019 Sep;286(17):3333-3339. doi: 10.1111/febs.14939. Epub 2019 Jun 10. FEBS J. 2019. PMID: 31144442 Free PMC article. Review. - Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.
Cruz-Torres I, Backos DS, Herson PS. Cruz-Torres I, et al. Mol Pharmacol. 2020 Feb;97(2):102-111. doi: 10.1124/mol.119.117549. Epub 2019 Nov 26. Mol Pharmacol. 2020. PMID: 31772034 Free PMC article. - Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Page BDG, Valerie NCK, Wright RHG, Wallner O, Isaksson R, Carter M, Rudd SG, Loseva O, Jemth AS, Almlöf I, Font-Mateu J, Llona-Minguez S, Baranczewski P, Jeppsson F, Homan E, Almqvist H, Axelsson H, Regmi S, Gustavsson AL, Lundbäck T, Scobie M, Strömberg K, Stenmark P, Beato M, Helleday T. Page BDG, et al. Nat Commun. 2018 Jan 17;9(1):250. doi: 10.1038/s41467-017-02293-7. Nat Commun. 2018. PMID: 29343827 Free PMC article. - Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors.
Shahbazi M, Wheeler HE, Armstrong GT, Frisina RD, Travis LB, Dolan ME. Shahbazi M, et al. Sci Rep. 2024 Nov 14;14(1):27952. doi: 10.1038/s41598-024-78274-w. Sci Rep. 2024. PMID: 39543288 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases